Christopher Aston to Coronary Disease
This is a "connection" page, showing publications Christopher Aston has written about Coronary Disease.
Connection Strength
0.284
-
Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American black women. Atherosclerosis. 1995 Sep; 117(1):73-81.
Score: 0.121
-
Racial and genetic determinants of plasma factor XIII activity. Genet Epidemiol. 2000 Dec; 19(4):440-55.
Score: 0.043
-
DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am J Hum Genet. 1998 Jan; 62(1):36-44.
Score: 0.036
-
A dietary and behavioral intervention designed to lower coronary heart disease. Risk factors are unaffected by variation at the APOE gene locus. Atherosclerosis. 1997 Jul 25; 132(2):221-7.
Score: 0.034
-
Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol. 1997 Jun; 17(6):1067-73.
Score: 0.034
-
Plasma apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) concentrations in normoglycemic Hispanics and non-Hispanic whites from the San Luis Valley, Colorado. Am J Epidemiol. 1997 Dec 15; 146(12):1011-8.
Score: 0.009
-
The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis. 1995 Jan 20; 112(2):145-59.
Score: 0.007